Senti Bio to Present Preclinical Advances on Pipeline Candidate SENTI-202 at ASH 2021 Annual Meeting

NEXT STORY
Affimed Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition and Company-sponsored Event on AFM13
PREV STORY
X4 Pharmaceuticals to Have Strong Presence at ASH 2021 with Seven Accepted Abstracts Highlighting New Clinical and Scientific Data; Company Reports Third Quarter Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Will Reach USD 547.60 Million by 2022: Zion Market Research

Sarasota, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Announces Clinical Presentations of SL-801 and SL-701 at the Upcoming ASCO Annual Meeting

author_avatar
NASDAQ Market News